An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Videos|July 24, 2018
MDS and AML Biology
Author(s)Aplastic Anemia, MDS International Foundation
Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Advertisement
Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Advertisement
Related to this article
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Advertisement
Advertisement
Trending on CURE
1
What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
4
Finding My Rhythm Again: What Fall Means to Me After Cancer
5